Supplement Firms Confounded By Identity Testing Waiver Process

FDA says it has not received any petitions to request an exemption from the 100% supplement ingredient identity testing requirement. Food and drug attorneys say the hassle of preparing a petition for a waiver outweighs the potential benefits

More from United States

More from North America